The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2025
Filed:
May. 02, 2017
Applicant:
The Regents of the University of Michigan, Ann Arbor, MI (US);
Inventors:
Steven P. Schwendeman, Superior Township, MI (US);
Rae Sung Chang, Ann Arbor, MI (US);
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Ann Arbor, MI (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/34 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/34 (2017.01); A61L 27/18 (2006.01); A61L 27/54 (2006.01); A61L 27/58 (2006.01); C07K 16/22 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0051 (2013.01); A61K 9/0024 (2013.01); A61K 47/26 (2013.01); A61K 47/34 (2013.01); A61L 27/18 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 27/58 (2013.01); C07K 16/22 (2013.01); A61L 2300/252 (2013.01); A61L 2300/256 (2013.01); A61L 2430/16 (2013.01); C07K 2317/24 (2013.01);
Abstract
Implants for anti-VEGF therapy provide both stability and controlled release of bevacizumab and other structurally sensitive polypeptides while maintaining protein/peptide stability in the micronized powder; achieving near zero order and complete release (>80%). Cylindrical implants suitable for intravitreal injection.